These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715 [TBL] [Abstract][Full Text] [Related]
3. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma. Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163 [TBL] [Abstract][Full Text] [Related]
4. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. Zhang T; Wang F; Wu JY; Qiu ZC; Wang Y; Liu F; Ge XS; Qi XW; Mao Y; Hua D World J Gastroenterol; 2018 Aug; 24(31):3538-3546. PubMed ID: 30131660 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients. Bin Z; Guangbo Z; Yan G; Huan Z; Desheng L; Xueguang Z J Surg Res; 2014 May; 188(2):396-403. PubMed ID: 24630518 [TBL] [Abstract][Full Text] [Related]
6. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer. Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365 [TBL] [Abstract][Full Text] [Related]
7. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer]. Shao Y; Shi T; Guo L; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. Zhang T; Jiang B; Zou ST; Liu F; Hua D World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945 [TBL] [Abstract][Full Text] [Related]
9. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer. Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027 [TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma. Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma. Mao Y; Sun J; Wang WP; Zhang XG; Hua D Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607 [TBL] [Abstract][Full Text] [Related]
12. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway. Jiang B; Liu F; Liu Z; Zhang T; Hua D Tumour Biol; 2016 Jul; 37(7):9465-72. PubMed ID: 26787540 [TBL] [Abstract][Full Text] [Related]
13. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Ma Y; Zhan S; Lu H; Wang R; Xu Y; Zhang G; Cao L; Shi T; Zhang X; Chen W Cell Death Dis; 2020 Oct; 11(10):824. PubMed ID: 33011740 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Sun J; Chen LJ; Zhang GB; Jiang JT; Zhu M; Tan Y; Wang HT; Lu BF; Zhang XG Cancer Immunol Immunother; 2010 Aug; 59(8):1163-71. PubMed ID: 20333377 [TBL] [Abstract][Full Text] [Related]
15. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Kim GE; Kim NI; Park MH; Lee JS Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells. Zhang P; Chen Z; Ning K; Jin J; Han X Biochem Biophys Res Commun; 2017 Aug; 490(3):1132-1138. PubMed ID: 28676400 [TBL] [Abstract][Full Text] [Related]
17. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834 [TBL] [Abstract][Full Text] [Related]
18. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance. Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032 [TBL] [Abstract][Full Text] [Related]
19. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients. Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786 [TBL] [Abstract][Full Text] [Related]
20. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]